Biostatistics: a fundamental discipline at the core of modern health data science

28 October 2019 - The value of our health and medical research investment is at risk unless we foster the discipline ...

Read more →

High health care costs suggest review is needed: report

8 October 2019 - The federal government’s annual $6 billion spend on the health insurance rebate could be redirected to ...

Read more →

ICER identifies costliest US drug-price hikes that are not supported by new clinical evidence

8 October 2019 - In 2017 and 2018, out of nine identified drugs that had substantial price increases on top of ...

Read more →

Bad diagnosis: health care system muddled, lacking leadership major report finds

3 September 2019 - The review is being led by former prime minister Helen Clark's chief of staff, Heather Simpson. ...

Read more →

An international perspective on the paradoxes of US health care

28 August 2019 - Each year, the Commonwealth Fund selects an international cohort of Harkness Fellows in health care policy ...

Read more →

Academics and researchers raise concerns with FDA’s plan for ‘integrated reviews’

28 August 2019 - More than 50 academics and researchers from Harvard, Yale, Johns Hopkins and other universities around the ...

Read more →

Australian Public Assessment Reports for prescription medicines

28 August 2019 - TGA is reviewing the operation of transparency measures and are considering activities to increase transparency of ...

Read more →

Patient Voice Aotearoa calls for PHARMAC reform

28 August 2019 - Patient Voice Aotearoa has launched a petition calling for the Minister of Health to initiate an ...

Read more →

ICER Proposes Updates to 2020 Value Assessment Framework Methods and Procedures

21 August 2019 - Reflecting experience with current framework, benchmarking with other HTA groups, and public input, proposals include new emphasis ...

Read more →

FDA should take additional steps to address factors that may affect approval rates in the first review cycle

7 August 2019 - Companies that make generic drugs—which have the same active ingredients as brand-name drugs—have to apply for ...

Read more →

Reforms to the generic medicine market authorisation process

30 July 2019 - The TGA would like to thank respondents who provided submissions in response to the public consultation ...

Read more →

FDA’s Sharpless outlines FDA's 4 top priorities: tech, hiring, modernisation and increased safety

24 July 2019 - Acting U.S. FDA Commissioner Ned Sharpless emailed agency staff yesterday outlining the FDA’s four main priorities. ...

Read more →

U.S. District Court orders FDA to reconsider application for final approval of Brixadi (buprenorphine) extended release injection for the treatment of opioid use disorder

23 July 2019 - The U.S. District Court for the District of Columbia granted Braeburn’s motion for summary judgment, vacating ...

Read more →

NICE numbers at 20

19 July 2019 - Leela Barham takes a look at NICE’s stats on technology appraisals to see how the agency ...

Read more →

NICE announces details of health technology evaluation methods review

22 July 2019 - Following approval at its recent Board meeting NICE has confirmed the details of its review of the ...

Read more →